RhyGaze

RhyGaze is developing a new gene therapy aimed at restoring patients' vision. The company's treatment technology specifically delivers photoreceptor genes to cone cells that have lost light sensitivity, repairing their ability to detect light and enabling the healthcare industry to provide vision restoration for blind patients.